These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 720712)

  • 41. Effect of vitamin A treatment on the immune reactivity of patients with systemic lupus erythematosus.
    Vien CV; González-Cabello R; Bodó I; Gergely P
    J Clin Lab Immunol; 1988 May; 26(1):33-5. PubMed ID: 3184159
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The significance of antibodies to DNA nucleoprotein, complement and granulocyte phagocytosis in the production of LE cells].
    Horvat Z; Cikes N
    Lijec Vjesn; 1983 Oct; 105(10):396-9. PubMed ID: 6197600
    [No Abstract]   [Full Text] [Related]  

  • 43. [Circulating immune complexes and clinico-immunologic subtypes of systemic lupus erythematosus. II].
    Nasonov EL; Solov'ev SK; Poverennyĭ AM; Ivanova MM; Tachmuradova MD
    Ter Arkh; 1989; 61(5):38-43. PubMed ID: 2781488
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antigranulocyte antibodies in patients with systemic lupus erythematosus (SLE).
    Sipos A; Seres T; Szegedi G
    Acta Med Hung; 1987; 44(4):299-310. PubMed ID: 3444710
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Serum complements and circulating immune complex in patients with systemic lupus erythematosus].
    Tang HY
    Zhonghua Yi Xue Za Zhi; 1983 Feb; 63(2):83-6. PubMed ID: 6407735
    [No Abstract]   [Full Text] [Related]  

  • 46. [The use of taktivin for modulating the functional activity of the neutrophilic granulocytes in patients with systemic lupus erythematosus].
    Romanov VA; Borodin AG; Krylov VL
    Ter Arkh; 1992; 64(5):65-9. PubMed ID: 1455381
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Intervention of heparin in immunological phenomena: reversibility of the nuclear antigen and antinuclear antibody reaction in systemic lupus erythematosus].
    Bardare M; Menghi P
    Boll Soc Ital Biol Sper; 1965 Jul; 41(13):713-5. PubMed ID: 4164914
    [No Abstract]   [Full Text] [Related]  

  • 48. The production of antibody-dependent cellular cytotoxicity by immune complexes in systemic lupus erythematosus.
    Penning CA; Hughes P; Rowell NR
    J Clin Lab Immunol; 1984 Mar; 13(3):123-7. PubMed ID: 6716450
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Constellation types of immunological reactions in lupus erythematosus].
    Glavinskaia TA; Dobrotina NA; Pavlova LT; Komarova VD; Efimochkina TK
    Vestn Dermatol Venerol; 1977 Feb; (2):3-8. PubMed ID: 855431
    [No Abstract]   [Full Text] [Related]  

  • 50. [Detection of circulating immune complexes in systemic lupus erythematosus by the method of conglutinin and monoclonal rheumatoid factor].
    de Oliveira RM; Marchiori PE; Viana Vdos S; Bueno C; dos Reis M; Quevedo ME; Cossermelli W
    Rev Hosp Clin Fac Med Sao Paulo; 1985; 40(1):6-9. PubMed ID: 4059787
    [No Abstract]   [Full Text] [Related]  

  • 51. [Antibodies against soluble nuclear antigens of the SS-A or SS-B type. Significance in systemic lupus erythematosis (author's transl)].
    Meyer O; Haim T
    Nouv Presse Med; 1981 Jun; 10(26):2179-84. PubMed ID: 6973748
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [A case of inflammatory vitiligo associated with lupus erythematosus (author's transl)].
    Masutani M; Shoji M; Taneda A; Ogawa H; Miyazaki H
    Nihon Hifuka Gakkai Zasshi; 1975 Aug; 85(9):525-31. PubMed ID: 1081161
    [No Abstract]   [Full Text] [Related]  

  • 53. [Delayed hypersensitivity in systemic lupus erythematosus (author's transl)].
    Sakurami T; Fukase M
    Nihon Hifuka Gakkai Zasshi; 1975 Oct; 85(12):699-702. PubMed ID: 1238717
    [No Abstract]   [Full Text] [Related]  

  • 54. [Lymphoreceptopathy in the patients with systemic lupus erythematosus (author's transl)].
    Arimori S
    Nihon Naika Gakkai Zasshi; 1980 Dec; 69(12):1584-9. PubMed ID: 7229477
    [No Abstract]   [Full Text] [Related]  

  • 55. An immunoelectrophoretic analysis of antigens reacting with lupus serum.
    ATCHLEY WA
    Arthritis Rheum; 1961 Oct; 4():471-9. PubMed ID: 13863073
    [No Abstract]   [Full Text] [Related]  

  • 56. [Autoimmune diseases involving multiple organ systems with special reference to SLE (author's transl)].
    Fukase M
    Nihon Naika Gakkai Zasshi; 1975 Aug; 64(8):753-70. PubMed ID: 1239473
    [No Abstract]   [Full Text] [Related]  

  • 57. [THE SIGNIFICANCE OF FAMILIAL EXAMINATIONS IN LUPUS ERYTHEMATOSUS].
    APOSTOLOFF G; SOENNICHSEN N; RANDOW U; WEIDAUER S; ZOELLNER E
    Dermatol Wochenschr; 1965 Apr; 151():363-70. PubMed ID: 14304124
    [No Abstract]   [Full Text] [Related]  

  • 58. In vitro and in vivo interaction of nuclear antibodies with corresponding antigens.
    Barnes GW; Sullivan MA; Beutner EH; Witebsky E
    Experientia; 1965 Aug; 21(8):485-8. PubMed ID: 5870934
    [No Abstract]   [Full Text] [Related]  

  • 59. Induction of lupus inclusions by BUdR is mediated by a human lymphoid cell factor.
    Rich SA
    Arthritis Rheum; 1981 Nov; 24(11):1444-7. PubMed ID: 6274360
    [No Abstract]   [Full Text] [Related]  

  • 60. [Increased immune reactivity in Systemic lupus erythematosus. IV. enhanced activity of a granulocyte adherence inhibiting factor after immunization with brucella antigen (author's transl)].
    Günither W; Diezel W; Sönnichsen N
    Dermatol Monatsschr; 1978 Nov; 164(11):809-12. PubMed ID: 720712
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.